Abstract
In this study, the synthesis, anti-inflammatory and analgesic activities of eight new 5-thioalkyl-1,3-diaryl-1,2,4- triazole derivatives were reported. For the anti-inflammatory study, the carrageenan-induced rat paw edema model was used. The test compounds in 50 mg/kg and 100 mg/kg were injected as IP and paw edema was determined. The results showed that some of the compounds have good activity compared to the references drug, indomethacin. For analgesic activity, the test compounds were studied using the in Tail-flick test model in 50 and 100 mg/kg as IP injections. Their analgesic activities were determined after 30 min via latency time assay. Statistical analysis showed that all test compounds have antinociceptive activity in the range of 24% -47% as compared to the control with a dose of 50 mg/kg. However, all tested compounds have analgesic activity lower than the standard drug, morphine.
Keywords: Anti-inflammatory activity, analgesic activity, 1, 2, 4-tiazole derivatives, diarylheterocyclic compounds.
Graphical Abstract
Medicinal Chemistry
Title:Synthesis and Evaluation of Anti-inflammatory and Analgesic Activities of New 1,2,4-triazole Derivatives
Volume: 11 Issue: 1
Author(s): Fatemeh Ahmadi, Mohsen Rezayan Ghayahbashi, Mohammad Sharifzadeh, Eskandar Alipoiur, Seyed Nasser Ostad, Mohsen Vosooghi, Hamid Reza khademi and Mohsen Amini
Affiliation:
Keywords: Anti-inflammatory activity, analgesic activity, 1, 2, 4-tiazole derivatives, diarylheterocyclic compounds.
Abstract: In this study, the synthesis, anti-inflammatory and analgesic activities of eight new 5-thioalkyl-1,3-diaryl-1,2,4- triazole derivatives were reported. For the anti-inflammatory study, the carrageenan-induced rat paw edema model was used. The test compounds in 50 mg/kg and 100 mg/kg were injected as IP and paw edema was determined. The results showed that some of the compounds have good activity compared to the references drug, indomethacin. For analgesic activity, the test compounds were studied using the in Tail-flick test model in 50 and 100 mg/kg as IP injections. Their analgesic activities were determined after 30 min via latency time assay. Statistical analysis showed that all test compounds have antinociceptive activity in the range of 24% -47% as compared to the control with a dose of 50 mg/kg. However, all tested compounds have analgesic activity lower than the standard drug, morphine.
Export Options
About this article
Cite this article as:
Ahmadi Fatemeh, Ghayahbashi Rezayan Mohsen, Sharifzadeh Mohammad, Alipoiur Eskandar, Ostad Nasser Seyed, Vosooghi Mohsen, khademi Reza Hamid and Amini Mohsen, Synthesis and Evaluation of Anti-inflammatory and Analgesic Activities of New 1,2,4-triazole Derivatives, Medicinal Chemistry 2015; 11 (1) . https://dx.doi.org/10.2174/1573406410666140613154507
DOI https://dx.doi.org/10.2174/1573406410666140613154507 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Quantitative Structure-Activity Relationship Studies on Nitric Oxide Synthase Inhibitors
Current Enzyme Inhibition The Molecular Recognition Paradigm of Environmental Chemicals with Biomacromolecules
Current Protein & Peptide Science Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening
Current Pharmaceutical Design Recent Advances on Liquid Chromatographic and Mass Spectrometric Analysis of Selective Estrogen Receptor Modulators (SERMs) in Biological Fluids
Current Chromatography Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Anticancer Activity of Ferrocenylthiosemicarbazones
Anti-Cancer Agents in Medicinal Chemistry Ligand-Based Computer-Aided Discovery of Tyrosinase Inhibitors. Applications of the TOMOCOMD-CARDD Method to the Elucidation of New Compounds
Current Pharmaceutical Design Neuroprotective Role of Nanoparticles Against Alzheimer's Disease
Current Drug Metabolism Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Antiproliferative and Genotoxic Action of an Underexploited Organoteluran Derivative on Sarcoma 180 Cells
Anti-Cancer Agents in Medicinal Chemistry Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Rα Signaling
Current Gene Therapy Efficacy and Cardiovascular Safety of Thiazolidinediones
Current Drug Safety Matrix Metalloproteinases
Current Medicinal Chemistry Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry Inhibition of Alkaline Phosphatase: An Emerging New Drug Target
Mini-Reviews in Medicinal Chemistry Heteroaromatization with 4-Phenyldiazenyl-1-naphthol. Part IV: Synthesis of Some New Heterocyclic Compounds with Potential Biological Activity
Current Organic Synthesis Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry